Pinnacle Holdings’s ProShares UltraShort Health Care RXD Stock Holding History

Pinnacle Holdings’s Portfolio RXD Stock Details RXD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50	Closed	-$1.38K	–	228
2022 Q2	$1.38K	Buy	+50	New	+$1.36K	﹤0.01%	223

Other funds holding RXD

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pinnacle Holdings's RXD Position: Q3 2022 in Review

Pinnacle Holdings sold out of ProShares UltraShort Health Care (RXD) in Q3 2022, closing a stake of 50 shares — an estimated $1.38K sold.

Pinnacle Holdings first reported a position in RXD in Q2 2022 and held it in 1 quarter. The position peaked at $1.38K in Q2 2022. 3 funds tracked by Wall St. Rank hold RXD as of Q3 2022.

Pinnacle Holdings reported no remaining ProShares UltraShort Health Care position as of Q3 2022 after selling out during the quarter.
Pinnacle Holdings sold 50 ProShares UltraShort Health Care shares in Q3 2022, an estimated $1.38K.
Pinnacle Holdings first reported a position in ProShares UltraShort Health Care in Q2 2022 and held it in 1 quarter.
Pinnacle Holdings's ProShares UltraShort Health Care position peaked at $1.38K in Q2 2022.
3 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q3 2022.

Based on Pinnacle Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.